Skip to content
10-Q

Quarterly Report

MEDINOTEC, INC. MDNC

0001663577-24-000191

← back to feed
Filed
Jul 12, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Jul 10, 2024 11.73M sh
Current Liabilities Q1 2025 · May 31, 2024 $771.75K
Current Liabilities Q1 2025 · Feb 29, 2024 $827.45K
Total Liabilities Q1 2025 · May 31, 2024 $2.07M
Total Liabilities Q1 2025 · Feb 29, 2024 $2.64M
Current Assets Q1 2025 · May 31, 2024 $3.94M
Current Assets Q1 2025 · Feb 29, 2024 $4.38M
Total Assets Q1 2025 · May 31, 2024 $4.32M
Total Assets Q1 2025 · Feb 29, 2024 $4.8M
Operating Cash Flow Q1 2025 · May 31, 2023 −$274.72K
Cash And Equivalents Q1 2025 · May 31, 2023 $2.71M
Cash And Equivalents Q1 2025 · Feb 28, 2023 $2.83M
Stockholders Equity Q1 2025 · May 31, 2023 $2.62M
Stockholders Equity Q1 2025 · Feb 28, 2023 $2.56M
Eps Basic Q1 2025 · May 31, 2023 $0.00
Sga Expense Q1 2025 · May 31, 2023 −$216.12K
Rd Expense Q1 2025 · May 31, 2023 −$2.26K
Net Income Q1 2025 · May 31, 2023 $22.29K
Operating Income Q1 2025 · May 31, 2023 $40.85K
Gross Profit Q1 2025 · May 31, 2023 $317.71K
Cost Of Revenue restated Q1 2025 · May 31, 2023 −$98.5K
Revenue Q1 2025 · May 31, 2023 $416.21K